Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Joaquim, Luis F ^a,b   Farah, Vera M ^a   Bernatova, Iveta ^a,c   Fazan Jr , Rubens ^b   Grubbs, Robert ^a   Morris, Mariana ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cardiovascular; Cholinergic; Spectral analysis; Stress biology

Indexed keywords

CHOLINESTERASE; PYRIDOSTIGMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; FREQUENCY ANALYSIS; FREQUENCY MODULATION; HEART RATE; HEART RATE VARIABILITY; MALE; MOUSE; NONHUMAN; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSE RATE; SENSITIVITY ANALYSIS; STRESS; TIME;

ANIMALS; BAROREFLEX; CHOLINESTERASE INHIBITORS; HEART RATE; MALE; MICE; MICE, INBRED C57BL; PULSE; PYRIDOSTIGMINE BROMIDE; STRESS;

EID: 3042668002     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01136.2003     Document Type: Article

References (54)

1. Abdel-Rahman A, Shetty AK, and Abou-Donia MB. Disruption of the blood-brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of Gulf-War syndrome. Neurobiol Dis 10: 306-326, 2002.
2. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, and Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213: 220-222, 1981.
3. Baselli G, Cerutti S, Civardi S, Liberati D, Lombardi F, Malliani A, and Pagani M. Spectral and cross-spectral analysis of heart rate and arterial blood pressure variability signals. Comput Biomed Res 19: 520-534, 1986.
4. Beck KD, Brennan FX, Moldow RL, Ottenweller JE, Zhu G, and Servatius RJ. Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects. Life Sci 73: 41-51, 2003.
5. Behling A, Moraes RS, Rohde LE, Ferlin EL, Nobrega AC, and Ribeiro JP. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am Heart J 146: 494-500, 2003.
6. Bernatova I, Dubovicky M, Price WA, Grubbs RD, Lucot JB, and Morris M. Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. Pharmacol Biochem Behav 74: 901-907, 2003.
7. Bernatova I, Key MP, Lucot JB, and Morris M. Circadian differences in stress-induced pressor reactivity in mice. Hypertension 40: 768-773, 2002.
8. Borland RG, Brennan DH, Nicholson AN, and Smith PA. Studies on the possible central and peripheral effects in man of a cholinesterase inhibitor (pyridostigmine). Hum Toxicol 4: 293-300, 1985.
9. Cook JE, Kolka MA, and Wenger CB. Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment. Mil Med 157: 250-254, 1992.
10. Cooley RL, Montano N, Cogliati C, van de BP, Richenbacher W, Oren R, and Somers VK. Evidence for a central origin of the low-frequency oscillation in RR-interval variability. Circulation 98: 556-561, 1998.
11. DeBoer RW, Karemaker JM, and Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol Heart Circ Physiol 253: H680-H689, 1987.
12. Dias da Silva VJ, Viana P, de M, Fazan R Jr, Ruscone TG, Porta A, Malliani A, Salgado HC, and Montano N. Intravenous amiodarone modifies autonomic balance and increases baroreflex sensitivity in conscious rats. Auton Neurosci 95: 88-96, 2002.
13. Ellman GL, Courtney KD, Andres V Jr, and Featherstone RM. A new and rapid colimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95, 1961.
14. Everson SA, Lynch JW, Kaplan GA, Lakka TA, Sivenius J, and Salonen JT. Stress-induced blood pressure reactivity and incident stroke in middle-aged men. Stroke 32: 1263-1270, 2001.
15. Farah VD, Joaquim LF, Irigoyen MC, and Morris M. Cholinergic input is critical in the regulation of heart rate variability and stress reactivity in mice (Abstract). Hypertension 42: 411, 2003.
16. Fazan R Jr, Oliveira M, Dias da Silva VJ, Chapleau M, and Salgado HC. Blood pressure and heart rate variability spectra in conscious sino-aortic denervated C57BL mice (Abstract). FASEB J 17: A1230, 2003.
17. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, and Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 2: 1382-1385, 1996.
18. Galinier M, Pathak A, Fourcade J, Androdias C, Curnier D, Varnous S, Boveda S, Massabuau P, Fauvel M, Senard JM, and Bounhoure JP. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 21: 475-482, 2000.
19. Gawron VJ, Schiflett SG, Miller JC, Slater T, and Ball JF. Effects of pyridostigmine bromide on in-flight aircrew performance. Hum Factors 32: 79-94, 1990.
20. Goldberg AD, Becker LC, Bonsall R, Cohen JD, Ketterer MW, Kaufman PG, Krantz DS, Light KC, McMahon RP, Noreuil T, Pepine CJ, Raczynski J, Stone PH, Strother D, Taylor H, and Sheps DS. Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation 94: 2402-2409, 1996.
21. Grauer E, Alkalai D, Kapon J, Cohen G, and Raveh L. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol Appl Pharmacol 164: 301-304, 2000.
22. Grossman P, Watkins LL, Wilhelm FH, Manolakis D, and Lown B. Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease. Am J Cardiol 78: 1424-1427, 1996.
23. Haley RW, Hom J, Roland PS, Bryan WW, Van Ness PC, Bonte FJ, Devous MD, Mathews D, Fleckenstein JL, Wians FH, Wolfe GI, and Kurt TL. Evaluation of neurologic function in Gulf War veterans. JAMA 277: 223-230, 1997.
24. Haley RW and Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. JAMA 277: 231-237, 1997.
25. Haley RW, Kurt TL, and Hom J. Is there a Gulf War syndrome? JAMA 277: 215-222, 1997.
26. Janssen BJ, Leenders PJ, and Smits JF. Short-term and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol 278: R215-R225, 2000.
27. Japundzic N, Grichois ML, Zitoun P, Laude D, and Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. J Auton Nerv Syst 30: 91-100, 1990.
28. Johnson RP, Yang YL, and Gordon CJ. Peripheral cholinergic pathway modulates hyperthermia induced by stress in rats exposed to open-field stress. J Appl Physiol 92: 789-794, 2002.
29. Just A, Faulhaber J, and Ehmke H. Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol 279: R2214-R2221, 2000.
30. Kant GJ, Bauman RA, Feaster SR, Anderson SM, Saviolakis GA, and Garcia GE. The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. Pharmacol Biochem Behav 70: 209-218, 2001.
31. Kaufer D, Friedman A, Seidman S, and Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393: 373-377, 1998.
32. Keeler JR, Hurst CG, and Dunn MA. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 266: 693-695, 1991.
33. Key M, Frietze T, Bernatova I, Lucot JB, Paton SJ, Dubovicky M, and Morris M. Diumal rhythm in chronic stress responsiveness in mice (Abstract). FASEB J 16: A506, 2003.
34. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, and Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107: 565-570, 2003.
35. Li P, Sur SH, Mistlberger RE, and Morris M. Circadian blood pressure and heart rate rhythms in mice. Am J Physiol Regul Integr Comp Physiol 276: R500-R504, 1999.
36. Lisak RP. Myasthenia gravis. Curr Treat Options Neurol 1: 239-250, 1999.
37. Lucini D, Norbiato G, Clerici M, and Pagani M. Hemodynamic and autonomic adjustments to real life stress conditions in humans. Hypertension 39: 184-188, 2002.
38. Malliani A, Pagani M, Lombardi F, and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482-492, 1991.
39. Montano N, Gnecchi-Ruscone T, Porta A, Lombardi F, Malliani A, and Barman SM. Presence of vasomotor and respiratory rhythms in the discharge of single medullary neurons involved in the regulation of cardiovascular system. J Auton Nerv Syst 57: 116-122, 1996.
40. Nobrega AC, Carvalho AC, Santos KB, and Soares PP. Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress. Clin Auton Res 9: 11-16, 1999.
41. Nobrega AC, dos Reis AF, Moraes RS, Bastos BG, Ferlin EL, and Ribeiro JP. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin Auton Res 11: 11-17, 2001.
42. Pagani M, Somers V, Furlan R, Dell'Orto S, Conway J, Baselli G, Cerutti S, Sleight P, and Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 12: 600-610, 1988.
43. Pickering TG. Mental stress as a causal factor in the development of hypertension and cardiovascular disease. Curr Hypertens Rep 3: 249-254, 2001.
44. Reich P, DeSilva RA, Lown B, and Murawski BJ. Acute psychological disturbances preceding life-threatening ventricular arrhythmias. JAMA 246: 233-235, 1981.
45. Ropp SA, Paton SJ, Morris M, and Cool DR. Effect of subacute pyridostigmine and stress on hypothalamic and cerebral cortex acetylcholinesterase and proteomic profiles (Abstract). FASEB J 17: A622, 2003.
46. Rubini R, Porta A, Baselli G, Cerutti S, and Paro M. Power spectrum analysis of cardiovascular variability monitored by telemetry in conscious unrestrained rats. J Auton Nerv Syst 45: 181-190, 1993.
47. Sant'anna ID, de Sousa EB, de Moraes AV, Loures DL, Mesquita ET, and da Nobrega AC. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. Clin Sci (Lond) 105: 161-165, 2003.
48. Sharma HS and Dey PK. Influence of long-term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. J Neurol Sci 72: 61-76, 1986.
49. Sheps DS, McMahon RP, Becker L, Carney RM, Freedland KE, Cohen JD, Sheffield D, Goldberg AD, Ketterer MW, Pepine CJ, Raczynski JM, Light K, Krantz DS, Stone PH, Knatterud GL, and Kaufmann PG. Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation 105: 1780-1784, 2002.
50. Sinton CM, Fitch TE, Petty F, and Haley RW. Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the Rat. Toxicol Appl Pharmacol 165: 99-105, 2000.
51. Song X, Tian H, Bressler J, Pruett S, and Pope C. Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. Toxicol Sci 69: 157-164, 2002.
52. Stauss HM and Persson PB. Role of nitric oxide in buffering short-term blood pressure fluctuations. News Physiol Sci 15: 229-233, 2000.
53. Sundin O, Ohman A, Palm T, and Strom G. Cardiovascular reactivity, type A behavior, and coronary heart disease: comparisons between myocardial infarction patients and controls during laboratory-induced stress. Psychophysiology 32: 28-35, 1995.
54. sα. Circ Res 82: 416-423, 1998.